Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 3/2013

01-03-2013 | Letter to the Editor

Revised IPSS (IPSS-R) stratification and outcome of MDS patients treated with azacitidine

Authors: Massimo Breccia, Adriano Salaroli, Giuseppina Loglisci, Giuliana Alimena

Published in: Annals of Hematology | Issue 3/2013

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Greenberg P, Cox C, Le Beau MM, Fenaux P, Morel P, Sanz G et al (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89(6):2079–2088PubMed
2.
Greenberg PL, Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Solè F et al (2012) Revised international prognostic scoring system (IPSS-R) for myelodysplastic syndromes. Blood. doi:10.​1182/​blood-2012-03-420489
3.
Lamarque M, Raynaud S, Itzykson R, Thepot S, Quesnel B, Dreyfus F, et al. Impact of the provisional revised-IPSS (R-IPSS) in 265 MDS patients treated with azacitidine (AZA): the group Francophone des Myelodysplasies (GFM) experience. Blood 2011; 114: abstract 972
4.
Itzykson R, Thepot S, Quesnel B, Dreyfus F, Beyne-Rauzy O, Turlure P et al (2011) Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine. Blood 117(2):403–411PubMedCrossRef
Metadata
Title
Revised IPSS (IPSS-R) stratification and outcome of MDS patients treated with azacitidine
Authors
Massimo Breccia
Adriano Salaroli
Giuseppina Loglisci
Giuliana Alimena
Publication date
01-03-2013
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 3/2013
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-012-1581-4

Other articles of this Issue 3/2013

Annals of Hematology 3/2013 Go to the issue

Review Article

Hydroxyurea treatment in β-thalassemia patients: to respond or not to respond?

Original Article

Prognostic significance of expression levels of stem cell regulators MSI2 and NUMB in acute myeloid leukemia

Original Article

Effector mechanisms of sunitinib-induced G1 cell cycle arrest, differentiation, and apoptosis in human acute myeloid leukaemia HL60 and KG-1 cells

Original Article

A reduced curcuminoid analog as a novel inducer of fetal hemoglobin

Original Article

Blastic plasmacytoid dendritic cell neoplasm: a single-center experience

Original Article

Early death in patients diagnosed with non-Hodgkin’s lymphoma
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits